GlobalRPh Renal Dosing Masterv6.6
Source review / handoff

Piperacillin/tazobactam

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Return to full drug recordAll source differencesRead selected sourcesHow to use this review

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

All doses are total piperacillin plus tazobactam. The 30-minute source regimen is not an extended-infusion university regimen. The original PD summary and indication-specific CAPD table differ.

Check source scope before reading a dose

Stanford - piperacillin/tazobactam extended infusion

Product / population
Adults; IV fixed combination, guide page 7. Select one strategy.
Renal method
CrCl in mL/min; IHD and CRRT distinct.
Source revision
Revision date not stated in the reviewed page.
Retrieved
2026-09-05
Local review status
Locally included source-specific summary. Regimen differences are not automatically resolved.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

Three-hour and four-hour institutional protocols are not interchangeable

Sinai Health and UCSF differ in infusion duration, initial-to-maintenance timing, renal intervals and dialysis regimens. These are separate local pathways, not duplicate confirmations of one universal dose.

What to reconcile: Choose an approved institution-specific pathway with infection, susceptibility, dialysis settings and IV access documented. Do not pair one source's dose with the other's interval or loading sequence.

Source-specific interpretation; independent clinician adjudication pending.

Open this note and its source references

Label and UCSF dialysis instructions differ

The RX short-infusion table separates nosocomial pneumonia and other indications and specifies an HD supplement. UCSF lists a different all-infection intermittent-HD schedule.

What to reconcile: Keep the chosen regimen, infusion duration, indication and dialysis assumptions intact. Do not add the label supplement automatically to an institution's different regimen. Exactly 20 is also unassigned by UCSF's printed greater-than/less-than headings.

Source-specific interpretation; independent clinician adjudication pending.

Open this note and its source references

The ZOSYN table is a 30-minute infusion protocol

The mirror separates nosocomial pneumonia from other adult indications and specifies total combination grams.

What to reconcile: Do not attach an extended-infusion duration or another source interval to these short-infusion doses.

Source-specific interpretation; independent clinician adjudication pending.

Open this note and its source references
Professional

Stanford - piperacillin/tazobactam extended infusion

Open original reference

Stanford Health Care Antimicrobial Safety and Sustainability · Adults; IV fixed combination, guide page 7. Select one strategy.

Renal method: CrCl in mL/min; IHD and CRRT distinct.
Source date: Revision date not stated in the reviewed page.
Retrieved: 2026-09-05

Locally included source-specific summary. Regimen differences are not automatically resolved.

Dosing / renal protocol and limits

For CrCl >20 mL/min, 3.375-4.5 g IV every 8 hours over 4 hours; below 20, 3.375 g every 12 hours over 4 hours. IHD general infection: 2.25 g every 12 hours; severe infection: 3.375 g every 12 hours over 4 hours. CRRT extended infusion: 3.375-4.5 g every 8 hours over 4 hours. The source also provides short-infusion alternatives.

RDM30-060-piperacillin-tazo-1 · Source locator: Stanford - piperacillin/tazobactam extended infusion; renal/dosing sections and stated qualifiers

Source identity and provenance
Source
https://med.stanford.edu/content/dam/sm/bugsanddrugs/documents/antimicrobial-dosing-protocols/SHC-ABX-Dosing-Guide.pdf
Retrieved
2026-09-05
Renal-function method
CrCl in mL/min; IHD and CRRT distinct.
Source date/version
Revision date not stated in the reviewed page.
Hash meaning
Locally authored summary text; not original SPL, HTML or PDF bytes
Local summary SHA-256
900cb5d51b2c47b7940599cf8e31ab9248587329ea52cc25e094a8143f8dd153

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=piperacillin-tazo&s1=RDM30-060-piperacillin-tazo&h1=0b212d9d32af1da515ada460a307bc4768802d7a0e66c55424db0710bc0848d3